Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Integrate Brendan Technologies' Software with Protein Analysis Tools

NEW YORK (GenomeWeb News) - Invitrogen said today that it has signed an exclusive agreement with software developer Brendan Technologies to integrate the company’s StatLIA assay analysis software with its protein analysis tools.
Invitrogen said that the StatLIA software will be designed to work with protein quantitation via mass spectrometry, a technology platform that the company will add to its offerings when its planned acquisition of Applied Biosystems closes in the fall.
"This software maximizes the value of our reagents through state-of-the-art computations and analysis of proteomics mass spectrometry," said Kip Miller, Invitrogen's senior vice president of BioDiscovery, in a statement. "With the pending combination with Applied Biosystems, we will now have greater access to the mass spectrometry customers, allowing us to provide even more solutions addressing their needs."
Financial terms of the agreement were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.